## Answer
(model generated chain of thought explanation)

First, let's analyze the given information about drugs A and B:

1. Drugs A and B can act as both agonists and antagonists at a particular site.
2. Drug B is less potent than drug A.
3. When combined in the same solution, drug B reduces the potency (k_{max}) of drug A but increases its maximal efficacy (Emax).
4. If additional drug A is added to the solution, the maximal efficacy (Emax) of drug A increases.

From these points, we can infer that:

- Drug B acts as an antagonist at a particular site because it reduces the potency of drug A when combined in the same solution.
- The interaction between drugs A and B indicates that they have overlapping binding sites or mechanisms of action, which is consistent with competitive antagonism.

Now, let's analyze the information about drug C:

1. Drug C works on the same molecules as drugs A and B.
2. Drug C reduces the maximal efficacy (Emax) of drug A significantly when combined with drug A.
3. The interaction between drugs A and C indicates that they have overlapping binding sites or mechanisms of action, which is consistent with non-competitive antagonism.

Based on this analysis, we can conclude that:

Drug C acts as a competitive antagonist because it reduces the maximal efficacy (Emax) of drug A when combined with drug A, indicating that it competes with drug A for the same binding site.